Key Highlights

  • Blue Star Helium (ASX:BNL) shares finished the 6 November 2026 session at $0.105, up 12.90%.
  • First commercial helium sales and Revenue were achieved from the Pinon Canyon processing Facility during the September quarter.
  • The helium offtake agreement covering all Pinon Canyon output has been extended through March 2027.

During the Trading session on 6 November 2026, Blue Star Helium Limited (ASX:BNL) shares finished at $0.105, up 12.90%, while the S&P/ASX 200 fell 0.49% to 9,020.80. Blue Star is an exploration and production company focused on helium, with its main activity at the Galactica Project. The company's most recent update is its quarterly activities report for the quarter ended 30 September 2026, released on 30 October 2026.

Latest Development: Quarterly Activities Report (30 October 2026)

Blue Star reported that it achieved its first commercial helium sales and revenue from the Pinon Canyon processing facility at the Galactica Project, which it described as a significant milestone. Five tube trailers of helium were delivered during the quarter, with one further trailer delivered after quarter end.

The first tube trailer was delivered at spot market pricing, with subsequent deliveries completed under the helium offtake agreement with a major US industrial gases purchaser. Plant recovery and uptime improved through the quarter, supporting increased production and Fill rates.

Latest Development: Offtake and Revenue Outlook

The offtake agreement has been extended to cover all helium output from the Pinon Canyon facility through March 2027. The company expects revenue to ramp up into 2027, as output grows through further plant and gathering system refinement, additional development wells and deepening of existing wells. These steps are subject to permitting, equipment and contractor availability.

About the Company

Blue Star Helium is listed on the ASX and also has an over-the-counter listing in the United States. Its operations centre on helium production from the Galactica Project, with gas processed at the Pinon Canyon facility and sold in tube trailers to industrial customers.

Sector Context

Helium is used in medical imaging, semiconductor manufacturing, aerospace and scientific research, and Supply has been subject to periodic disruption. Smaller producers often sell to industrial gas companies under offtake agreements, which can give more predictable volumes than spot sales.

Risks to Watch

Revenue ramp-up depends on drilling, equipment and contractor availability, and on permitting. The offtake agreement runs only through March 2027, so pricing and volumes after that date are not yet contracted. Helium prices are exposed to changes in supply and demand.

Catalysts on Watch

Investors will be watching for the quarterly production and sales figures, any renewal of the offtake agreement beyond March 2027, and the progress of additional development wells. The next Quarterly Report will show whether delivered volumes are increasing.